2023 ISAKOS Biennial Congress ePoster
Functional Outcome of All-Soft-Tissue Quadriceps Tendon Autograft in ACL Reconstructions in Young and Sportive Patients at a Minimum Follow-Up of 1 Year
Thomas M. Tiefenboeck, MD, PhD, MSc AUSTRIA
Lorenz Pichler, MD, Vienna AUSTRIA
Harald Binder, MD, MSc., Wien AUSTRIA
Georg Kaiser, MD, Vienna AUSTRIA
Marcus Hofbauer, MD, PhD, Vienna AUSTRIA
Medical University of Vienna, Vienna, Vienna, AUSTRIA
FDA Status Cleared
Summary
The use of all-soft-tissue quadriceps tendon autograft technique can improve functional outcome in young and sportive patients with ACL injury at short to intermediate follow-up.
ePosters will be available shortly before Congress
Abstract
Purpose
To investigate the functional outcome in young and sportive patients with ACL injuries treated with an all-soft-tissue quadriceps tendon autograft at a minimum follow-up of 12 months.
Methods
Patients who received an QT autograft ACL reconstruction between August 2018 and December 2020 were included in this study. Range of motion in the operated knee was described at 6 and 18 weeks after surgery and functional outcome parameters (Lsyholm-Score, IKDC-Score and Tegner Activity Scale) were calculated at 6 and = 12 months months after surgery.
Results
40 patients were included in this study, of which 29 identified as male and 11 as female. The average age was 31.3 years (range 16 to 57 years) and the mean follow-up time 16.8 months (range 12 to 30 months). All functional outcome scores showed improvement over the course of the follow-up: Lysholm-Score 94.2 to 95.5 (n.s.), IKDC-Score 90.1 to 93.9 (n.s.), Tegner Activity Scale 3.7 to 5.0 (p>0.001), all at 6 months and =12 months. No reruptures happened during the time of the follow-up.
Conclusion
This study shows that the all-soft-tissue quadriceps tendon autograft technique can improve functional outcome in young and sportive patients with ACL injury at short to intermediate follow-up.